Next Article in Journal
Preclinical Testing of an Oncolytic Parvovirus in Ewing Sarcoma: Protoparvovirus H-1 Induces Apoptosis and Lytic Infection In Vitro but Fails to Improve Survival In Vivo
Previous Article in Journal
Virological Sampling of Inaccessible Wildlife with Drones
Open AccessArticle

Inhibition of Hepatitis E Virus Spread by the Natural Compound Silvestrol

Department of Virology, Paul-Ehrlich-Institut, 63225 Langen, Germany
Federal Institute for Risk Assessment, 10589 Berlin, Germany
Department of Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany
Institute of Pharmaceutical Chemistry, Philipps-Universität Marburg, 35037 Marburg, Germany
German Center for Infection Research (DZIF), 38124 Braunschweig, Germany
Author to whom correspondence should be addressed.
Viruses 2018, 10(6), 301;
Received: 19 April 2018 / Revised: 18 May 2018 / Accepted: 31 May 2018 / Published: 2 June 2018
(This article belongs to the Section Antivirals & Vaccines)
Every year, there are about 20 Mio hepatitis E virus (HEV) infections and 60,000 deaths that are associated with HEV worldwide. At the present, there exists no specific therapy for HEV. The natural compound silvestrol has a potent antiviral effect against the (−)-strand RNA-virus Ebola virus, and also against the (+)-strand RNA viruses Corona-, Picorna-, and Zika virus. The inhibitory effect on virus spread is due to an inhibition of the DEAD-box RNA helicase eIF4A, which is required to unwind structured 5′-untranslated regions (UTRs). This leads to an impaired translation of viral RNA. The HEV (+)-strand RNA genome contains a 5′-capped, short 5′-UTR. This study aims to analyze the impact of silvestrol on the HEV life cycle. Persistently infected A549 cells were instrumental. This study identifies silvestrol as a potent inhibitor of the release of HEV infectious viral particles. This goes along with a strongly reduced HEV capsid protein translation, retention of viral RNA inside the cytoplasm, and without major cytotoxic effects. Interestingly, in parallel silvestrol affects the activity of the antiviral major vault protein (MVP) by translocation from the cytoplasm to the perinuclear membrane. These data further characterize the complex antiviral activity of silvestrol and show silvestrol’s broad spectrum of function, since HEV is a virus without complex secondary structures in its genome, but it is still affected. View Full-Text
Keywords: HEV; silvestrol; antiviral; eIF4A; MVP HEV; silvestrol; antiviral; eIF4A; MVP
Show Figures

Figure 1

MDPI and ACS Style

Glitscher, M.; Himmelsbach, K.; Woytinek, K.; Johne, R.; Reuter, A.; Spiric, J.; Schwaben, L.; Grünweller, A.; Hildt, E. Inhibition of Hepatitis E Virus Spread by the Natural Compound Silvestrol. Viruses 2018, 10, 301.

AMA Style

Glitscher M, Himmelsbach K, Woytinek K, Johne R, Reuter A, Spiric J, Schwaben L, Grünweller A, Hildt E. Inhibition of Hepatitis E Virus Spread by the Natural Compound Silvestrol. Viruses. 2018; 10(6):301.

Chicago/Turabian Style

Glitscher, Mirco; Himmelsbach, Kiyoshi; Woytinek, Kathrin; Johne, Reimar; Reuter, Andreas; Spiric, Jelena; Schwaben, Luisa; Grünweller, Arnold; Hildt, Eberhard. 2018. "Inhibition of Hepatitis E Virus Spread by the Natural Compound Silvestrol" Viruses 10, no. 6: 301.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop